| __timestamp | Alkermes plc | Summit Therapeutics Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7753000 | 15635076 |
| Thursday, January 1, 2015 | 4019000 | 23943601 |
| Friday, January 1, 2016 | 2301000 | 23689111 |
| Sunday, January 1, 2017 | 7232000 | 41006114 |
| Monday, January 1, 2018 | 68895000 | 51379106 |
| Tuesday, January 1, 2019 | 52816000 | 32705593 |
| Wednesday, January 1, 2020 | 1946000 | 53274000 |
| Friday, January 1, 2021 | 1020000 | 85352000 |
| Saturday, January 1, 2022 | 393842000 | 51999000 |
| Sunday, January 1, 2023 | 270806000 | 59471000 |
| Monday, January 1, 2024 | 245326000 |
Unleashing insights
In the competitive world of biopharmaceuticals, research and development (R&D) investments are crucial for innovation and growth. Over the past decade, Summit Therapeutics Inc. and Alkermes plc have demonstrated contrasting strategies in their R&D expenditures.
Summit Therapeutics has shown a consistent commitment to R&D, with investments peaking in 2021 at approximately $85 million, a 445% increase from 2014. This steady growth underscores their dedication to pioneering new treatments.
Alkermes, on the other hand, experienced a dramatic surge in R&D spending in 2022, reaching nearly $394 million, a staggering 5,000% increase from 2014. This spike highlights a strategic pivot towards aggressive innovation.
Both companies illustrate the dynamic nature of R&D investment strategies, reflecting their unique approaches to driving future breakthroughs in the biopharma industry.
Research and Development Expenses Breakdown: Johnson & Johnson vs Alkermes plc
Comparing Innovation Spending: Pfizer Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for Bristol-Myers Squibb Company and Alkermes plc
Research and Development: Comparing Key Metrics for Biogen Inc. and Summit Therapeutics Inc.
Research and Development: Comparing Key Metrics for United Therapeutics Corporation and Summit Therapeutics Inc.
Research and Development Investment: Summit Therapeutics Inc. vs Geron Corporation
Summit Therapeutics Inc. or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Summit Therapeutics Inc. and Viridian Therapeutics, Inc.
Research and Development Investment: Exelixis, Inc. vs Alkermes plc
Research and Development Investment: Pharming Group N.V. vs Alkermes plc
Research and Development Investment: Corcept Therapeutics Incorporated vs Alkermes plc